Wow JTFM, you always find the nuggets. If I am reading this right, they will be using DNA based data to inform this. I suppose that is the other advantage the cancer center data bring.
While the size of the study will certainly bring credibility to the findings, won't the DNA connection and the precision afforded by this bring even more?
Oh, and Abbott has this covered as well as described on their website:
Molecular science is transforming the diagnosis and treatment of serious diseases – like certain infectious diseases and cancers. Abbott’s molecular diagnostics systems analyze DNA and RNA at the molecular level, guiding treatment decisions by providing more precise clinical tests or helping to identify highly targeted therapies most likely to be successful.
Visit www.abbottmolecular.com for more information.
News 
Market Data 
Discover 
